Importantly, compared to either non-target siRNA transfected or non-siRNA transfected fibroblasts, catalytic function of topo I of sumo1 siRNA transfected SSc fibroblasts showed a marked improvement in all three test fibroblast strains (Figure 5). This evidence concerns the gene SUMO1 and systemic sclerosis.